Along with common mutations such as ACVR1 and H3 K27M found in DIPG, 50% of DIPG cases harbor gain of function processes that stimulate tyrosine kinase receptors to trigger further tumor progression [2]. The gene discussed is ACVR1; the disease is diffuse intrinsic pontine glioma.